Effects of endothelin A receptor blockade in patients with ST-elevation acute coronary syndrome — A rhythmologic substudy

Life Sciences

Volumn 118, Issue 2, 2014, Pages 430-434

  Adlbrecht, Christopher ^a   Wurm, Raphael ^a   Pezawas, Thomas ^a   Andreas, Martin ^b   Redwan, Bassam ^a   Distelmaier, Klaus ^a   Kaider, Alexandra ^a   Lang, Irene M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Informatics and Intelligent Systems ^*  (Austria)

Author keywords

Acute myocardial infarction; Arrhythmia; BQ 123; Endothelin; Percutaneous coronary intervention; Reperfusion

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR; PLACEBO; ENDOTHELIN RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HEART BEAT; HEART VENTRICLE TACHYCARDIA; HOLTER MONITOR; HOLTER MONITORING; HUMAN; MALE; MEDICAL DOCUMENTATION; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; ST SEGMENT ELEVATION; SUPRAVENTRICULAR PREMATURE BEAT; ARRHYTHMIAS, CARDIAC; BIOASSAY; COMPLICATION; ECHOGRAPHY; METABOLISM; MIDDLE AGED;

ACUTE CORONARY SYNDROME; AGED; ARRHYTHMIAS, CARDIAC; ENDOTHELIN RECEPTOR ANTAGONISTS; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTOR, ENDOTHELIN A;

EID: 84895916185     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.02.015     Document Type: Article

References (48)

1. Adabag, A.S., Therneau, T.M., Gersh, B.J., Weston, S.A., Roger, V.L., Sudden death after myocardial infarction. JAMA 300 (2008), 2022–2029.
2. Bloch Thomsen, P.E., Jons, C., Raatikainen, M.J., Moerch Joergensen, R., Hartikainen, J., Virtanen, V., et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. Circulation 122 (2010), 1258–1264.
3. Camm, A.J., Pratt, C.M., Schwartz, P.J., Al-Khalidi, H.R., Spyt, M.J., Holroyde, M.J., et al. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 109 (2004), 990–996.
4. Solomon, S.D., Zelenkofske, S., McMurray, J.J., Finn, P.V., Velazquez, E., Ertl, G., et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005), 2581–2588.
5. Roberts, R., Husain, A., Ambos, H.D., Oliver, G.C., Cox, J.R. Jr., Sobel, B.E., Relation between infarct size and ventricular arrhythmia. Br Heart J 37 (1975), 1169–1175.
6. Crawford, T., Cowger, J., Desjardins, B., Kim, H.M., Good, E., Jongnarangsin, K., et al. Determinants of postinfarction ventricular tachycardia. Circ Arrhythm Electrophysiol 3 (2010), 624–631.
7. Adlbrecht, C., Bonderman, D., Plass, C., Jakowitsch, J., Beran, G., Sperker, W., et al. Active endothelin is an important vasoconstrictor in acute coronary thrombi. Thromb Haemost 97 (2007), 642–649.
8. Keltai, K., Vago, H., Zsary, A., Karadi, I., Kekesi, V., Juhasz-Nagy, A., et al. Endothelin gene expression during ischemia and reperfusion. J Cardiovasc Pharmacol 44:Suppl. 1 (2004), S198–S201.
9. Tonnessen, T., Giaid, A., Saleh, D., Naess, P.A., Yanagisawa, M., Christensen, G., Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ Res 76 (1995), 767–772.
10. Khan, S.Q., Dhillon, O., Struck, J., Quinn, P., Morgenthaler, N.G., Squire, I.B., et al. C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study. Am Heart J 154 (2007), 736–742.
11. Toth, M., Solti, F., Merkely, B., Kekesi, V., Horkay, F., Szokodi, I., et al. Ventricular tachycardias induced by intracoronary administration of endothelin-1 in dogs. J Cardiovasc Pharmacol 26:Suppl. 3 (1995), S153–S155.
12. Isaka, M., Kudo, A., Imamura, M., Kawakami, H., Yasuda, K., Endothelin receptors, localized in sympathetic nerve terminals of the heart, modulate norepinephrine release and reperfusion arrhythmias. Basic Res Cardiol 102 (2007), 154–162.
13. Alberola Aguilar, A.M., Revert, F., Moya, A., Beltran, J., Garcia, J., San Martin, E., et al. Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion. Gen Pharmacol 35 (2000), 143–147.
14. Baltogiannis, G.G., Tsalikakis, D.G., Mitsi, A.C., Hatzistergos, K.E., Elaiopoulos, D., Fotiadis, D.I., et al. Endothelin receptor–a blockade decreases ventricular arrhythmias after myocardial infarction in rats. Cardiovasc Res 67 (2005), 647–654.
15. Crockett, T.R., Scott, G.A., McGowan, N.W., Kane, K.A., Wainwright, C.L., Anti-arrhythmic and electrophysiological effects of the endothelin receptor antagonists, BQ-123 and PD161721. Eur J Pharmacol 432 (2001), 71–77.
16. Gelzer, A.R., Attmann, T., Radicke, D., Nydam, D., Candinas, R., Lutter, G., Effects of acute systemic endothelin receptor blockade on cardiac electrophysiology in vivo. J Cardiovasc Pharmacol 44 (2004), 564–570.
17. Lee, T.M., Chen, C.C., Lin, M.S., Chang, N.C., Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats. Am J Physiol Heart Circ Physiol 294 (2008), H1871–H1879.
18. Ozdemir, R., Parlakpinar, H., Polat, A., Colak, C., Ermis, N., Acet, A., Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury. Toxicology 219 (2006), 142–149.
19. Singh, A.D., Amit, S., Kumar, O.S., Rajan, M., Mukesh, N., Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats. Basic Clin Pharmacol Toxicol 98 (2006), 604–610.
20. Garjani, A., Wainwright, C.L., Zeitlin, I.J., Wilson, C., Slee, S.J., Effects of endothelin-1 and the ETA-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats. J Cardiovasc Pharmacol 25 (1995), 634–642.
21. Adlbrecht, C., Andreas, M., Redwan, B., Distelmaier, K., Mascherbauer, J., Kaider, A., et al. Systemic endothelin receptor blockade in ST-segment elevation acute coronary syndrome protects the microvasculature: a randomised pilot study. Eur Soc Cardiol 7 (2012), 1386–1395.
22. Adlbrecht, C., Wurm, R., Humenberger, M., Andreas, M., Redwan, B., Distelmaier, K., et al. Short-term endothelin-A receptor blockade improves long-term outcome in patients with ST-elevation acute myocardial infarction. Thromb Haemost, 2014 (in press).
23. Makikallio, T.H., Hoiber, S., Kober, L., Torp-Pedersen, C., Peng, C.K., Goldberger, A.L., et al. Fractal analysis of heart rate dynamics as a predictor of mortality in patients with depressed left ventricular function after acute myocardial infarction. TRACE Investigators. TRAndolapril Cardiac Evaluation. Am J Cardiol 83 (1999), 836–839.
24. Denniss, A.R., Richards, D.A., Cody, D.V., Russell, P.A., Young, A.A., Cooper, M.J., et al. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation 74 (1986), 731–745.
25. Gomes, J.A., Cain, M.E., Buxton, A.E., Josephson, M.E., Lee, K.L., Hafley, G.E., Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 104 (2001), 436–441.
26. Steinberg, J.S., Regan, A., Sciacca, R.R., Bigger, J.T. Jr., Fleiss, J.L., Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram. Am J Cardiol 69 (1992), 13–21.
27. Bauer, A., Guzik, P., Barthel, P., Schneider, R., Ulm, K., Watanabe, M.A., et al. Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J 26 (2005), 755–761.
28. Adlbrecht, C., Distelmaier, K., Gunduz, D., Redwan, B., Plass, C., Bonderman, D., et al. Target vessel reopening by guidewire insertion in ST-elevation myocardial infarction is a predictor of final TIMI flow and survival. Thromb Haemost 105 (2011), 52–58.
29. Spratt, J.C., Goddard, J., Patel, N., Strachan, F.E., Rankin, A.J., Webb, D.J., Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br J Pharmacol 134 (2001), 648–654.
30. Hoeper, M.M., Liver toxicity: the Achilles’ heel of endothelin receptor antagonist therapy?. Eur Respir J 34 (2009), 529–530.
31. Exner, D.V., Kavanagh, K.M., Slawnych, M.P., Mitchell, L.B., Ramadan, D., Aggarwal, S.G., et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 50 (2007), 2275–2284.
32. Kuchar, D.L., Thorburn, C.W., Sammel, N.L., Late potentials detected after myocardial infarction: natural history and prognostic significance. Circulation 74 (1986), 1280–1289.
33. Kalla, K., Christ, G., Karnik, R., Malzer, R., Norman, G., Prachar, H., et al. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation 113 (2006), 2398–2405.
34. Adlbrecht, C., Distelmaier, K., Bonderman, D., Beran, G., Redwan, B., Strunk, G., et al. Long-term outcome after thrombectomy in acute myocardial infarction. Eur J Clin Invest 40 (2010), 233–241.
35. Sharif, I., Kane, K.A., Wainwright, C.L., Endothelin and ischaemic arrhythmias–antiarrhythmic or arrhythmogenic?. Cardiovasc Res 39 (1998), 625–632.
36. Perez, M.V., Dewey, F.E., Marcus, R., Ashley, E.A., Al-Ahmad, A.A., Wang, P.J., et al. Electrocardiographic predictors of atrial fibrillation. Am Heart J 158 (2009), 622–628.
37. Mackenzie, L., Bootman, M.D., Laine, M., Berridge, M.J., Thuring, J., Holmes, A., et al. The role of inositol 1,4,5-trisphosphate receptors in Ca(2 +) signalling and the generation of arrhythmias in rat atrial myocytes. J Physiol 541 (2002), 395–409.
38. Kiss, O., Zima, E., Soos, P., Kekesi, V., Juhasz-Nagy, A., Merkely, B., Intracoronary endothelin-1 infusion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effects. Life Sci 75 (2004), 537–548.
39. Binici, Z., Intzilakis, T., Nielsen, O.W., Kober, L., Sajadieh, A., Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 121 (2010), 1904–1911.
40. Zoni Berisso, M., Carratino, L., Ferroni, A., De Caro, E., Mela, G.S., Vecchio, C., The relation between supraventricular tachyarrhythmias and left ventricular dysfunction after acute myocardial infarction. Acta Cardiol 43 (1988), 689–701.
41. Chong, B.H., Pong, V., Lam, K.F., Liu, S., Zuo, M.L., Lau, Y.F., et al. Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events. EUROPACE: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology., 14, 2012, 942–947.
42. Jabre, P., Jouven, X., Adnet, F., Thabut, G., Bielinski, S.J., Weston, S.A., et al. Atrial fibrillation and death after myocardial infarction: a community study. Circulation 123 (2011), 2094–2100.
43. Hreybe, H., Saba, S., Location of acute myocardial infarction and associated arrhythmias and outcome. Clin Cardiol 32 (2009), 274–277.
44. Bigger, J.T. Jr., Fleiss, J.L., Steinman, R.C., Rolnitzky, L.M., Kleiger, R.E., Rottman, J.N., Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 85 (1992), 164–171.
45. La Rovere, M.T., Bigger, J.T. Jr., Marcus, F.I., Mortara, A., Schwartz, P.J., Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351 (1998), 478–484.
46. Pekdemir, H., Cicek, D., Camsari, A., Akkus, M.N., Cin, V.G., Doven, O., et al. The relationship between plasma endothelin-1, nitric oxide levels, and heart rate variability in patients with coronary slow flow. Ann Noninvasive Electrocardiol 9 (2004), 24–33.
47. Chrysohoou, C., Metallinos, G., Athanasopoulou, S., Arsenos, P., Tsitsinakis, G., Dilaveris, P., et al. Reduced Heart Rate Variability Correlates With Anaemia and Impaired Quality of Life in Patients With Chronic Compensated Heart Failure. J Card Fail, 16, 2010, S81.
48. Nguyen, Q.T., Cernacek, P., Calderoni, A., Stewart, D.J., Picard, P., Sirois, P., et al. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat. Circulation 98 (1998), 2323–2330.